Jonas S. Jutzi

912 citations
21 papers · 422 indexed · h-index 10
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers)Acute Myeloid Leukemia Research (8 papers)Eosinophilic Disorders and Syndromes (6 papers)

In The Last Decade

Jonas S. Jutzi

20 papers receiving 422 citations

Peers

Jonas S. Jutzi
Comparison fields: 5 of 49
  • Genetics 282
  • Hematology 250
  • Molecular Biology 238
  • Rheumatology 109
  • Immunology 37
Replace Rodolphe Besancenot with:
Rodolphe Besancenot France
Hajime Akada United States
Tina L. Hamilton United Kingdom
Susanne Isfort Germany
Alessandro M. Vannucchi Italy
Jiřı́ Schwarz Czechia
Lawrence J. Breyfogle United States
Klaudia Bagienski Austria
Yumi Hironaka Japan
Sven Schwemmers Germany
Jonas S. Jutzi relative to Rodolphe Besancenot France Rodolphe Besancenot's profile →
Citations per field
00.5×9.2×
Rodolphe Besancenot · 1×
Citations per year

Countries citing papers authored by Jonas S. Jutzi

Since Specialization
Citations

This map shows the geographic impact of Jonas S. Jutzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas S. Jutzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas S. Jutzi more than expected).

Fields of papers citing papers by Jonas S. Jutzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas S. Jutzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas S. Jutzi. The network helps show where Jonas S. Jutzi may publish in the future.

Co-authorship network of co-authors of Jonas S. Jutzi

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas S. Jutzi. A scholar is included among the top collaborators of Jonas S. Jutzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas S. Jutzi. Jonas S. Jutzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 6
6 6
7 13
8 11
9 1
10 9
11 1
12 5
13 17
14 30
15 20
16 10
17 35
18 119
19 9
20 49

About Jonas S. Jutzi

Jonas S. Jutzi is a scholar working on Genetics, Hematology and Rheumatology, having authored 21 papers that have together received 422 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (8 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Genetics (282 citations), Hematology (250 citations) and Rheumatology (109 citations). Jonas S. Jutzi has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Heike L. Pahl, Ann Mullally, Christine Dierks, Francisco Cervantes, Tiziano Barbui, Rüdiger Hehlmann, Georg Jeryczynski, Peter Valent, Heinz Gisslinger and Hans Carl Hasselbalch. Their work appears in journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026